Cipla to invest in iCaltech to strengthen respiratory play
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
She was Group Chief Marketing Officer at CKA Birla Group in her last role
Upgrades 2025 full-year CDMO sales and margin outlook
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Subscribe To Our Newsletter & Stay Updated